Claris Law Legal Blogging Community

Recent Entries

RSS 2.0 feed Add to My Yahoo!
Add to Bloglines Add to your My Feedster
Add to your NewsGator My MSN
Trasylol Lawyer

Trasylol Discussion

editor photo

Editor: Jamie Sheller
Profession: Trasylol Attorney

February 21, 2008

By Paul Napoli

TrackBack (0)

New Studies Support Trasylol Risk

Category: Trasylol Discussion

Two studies have been published in the New England Journal of Medicine that support the increased risk of kidney failure following the use of Trasylol. The anti-bleeding drug Trasylol is used during open heart surgery to reduce blood loss. It was pulled from the market after a study was published last year showing the risk of death to be twice that of other drugs in the same class. Researchers have been trying to analyze data from patients to confirm or disprove the risk.

Continue reading "New Studies Support Trasylol Risk"

January 30, 2008

By Paul Napoli

TrackBack (0)

What to do about Adverse Drug Reactions

Category: Trasylol Discussion

Adverse drug reactions, especially those that are coupled with a major surgery, can be difficult to detect. The recent news that Trasylol may cause kidney failure, heart attacks, and strokes, has many patients wondering what to do next. There is a reported 106,000 deaths in the United States from adverse drug reactions each year.

Continue reading "What to do about Adverse Drug Reactions"

January 23, 2008

By Paul Napoli

TrackBack (0)

Risks Even with Established Drugs

Category: Trasylol Discussion

Even after a prescription drug has been on the market for many years there is no guarantee that they are safe. Recent drugs to go under the microscope are Vytorin, Trasylol, and Avandia. Vytorin is a cholesterol lowering drugs which studies say does not decrease the risk of heart attacks and strokes.

Continue reading "Risks Even with Established Drugs"

January 10, 2008

By Paul Napoli

TrackBack (0)

Trasylol in Open Heart Surgery

Category: Trasylol Discussion

According to the Food and Drug Administration (FDA) Trasylol has been approved for use in coronary artery bypass graft surgery (CABG) which is commonly known as heart bypass surgery. This is the only use of the drug that the FDA has approved. In November of 2007 the FDA asked Bayer for a marketing suspension of the drug following preliminary data from the BART study in Canada. The data was showing an increased risk of death following Trasylol use.

Continue reading "Trasylol in Open Heart Surgery"

December 11, 2007

By Paul Napoli

TrackBack (0)

Did Your Surgeon Use Trasyol?

Category: Trasylol Discussion

While undergoing surgery it may be unusual for a doctor or surgeon to discuss the exact medications and details of every procedure that will be performed on you. If you or a loved one has undergone open heart surgery in the last five years than you may want to find out what drugs were used, especially if there were any complications.

Continue reading "Did Your Surgeon Use Trasyol?"

December 05, 2007

By Paul Napoli

TrackBack (0)

February JAMA Report Showed Trasylol Risk

Category: Trasylol Discussion

A study published in the February 2007 edition of the Journal of the American Medical Association (JAMA) showed an increased risk of using the recalled drug Trasylol that continued for at least five years after surgery. The study analyzed data from 4374 patients. The researchers were calculating the survival rate of patients at six weeks, six months, and every year for five years.

Continue reading "February JAMA Report Showed Trasylol Risk"

May 24, 2006

By Staff Writer

TrackBack (0)

Why Are Doctors Still Using Trasylol?

Category: Trasylol Discussion

Given the article published in the New England Journal of Medicine describing the unjustified risk of renal failure, heart attacks and strokes, you have to wonder why this drug is still being used by heart surgeons. Two generics are available that don't have the risks of Trasylol. A major hint has to do with the incredible cost of Trasylol and the profits it helps to ensure to the drug company. Drug sales reps are pushing this drug on doctors as the only available alternative. What is even worse is the FDA is doing next to nothing to stop it. There is no reason for this drug to be on the market.

May 15, 2006

By Staff Writer

TrackBack (0)

Trasylol - not worth risk of dialysis

Category: Trasylol Discussion

Given that there were two generic equivalents to this drug, I don't see how doctors justified the use of Trasylol during heart surgery to control bleeding. Studies have shown the other choises were more effective and did not carry the risks of kidney damage. I assume drug company reps were making a big push for Trasylo, because it ids the one they could make a greater profit on, as it was more expensive.